Immunology Flashcards

1
Q

Innate immune system of the eye

A

Blink reflex

Physical and chemical properties of eye surface

Limit exposure/ size

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Blink reflex- tears

A

Tears: physical

  • flushing
  • mucous layer= anti-adhesive

Tears: chemical

  • lysozyme, lactoferrin, transferrin
  • tear lipids
  • angiogenin
  • secretory ILA
  • complement
  • Il-6, Il-8, MIP

Tears; cellular

  • neutrophils
  • macrophages
  • conjunctival mast cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Adaptive Immune system of eye

A

Antigen presenting cells (APCs)
- dendritic cells, B cells, macrophages

lymphatic drainage to. lymph node

Variety of effector cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Langerhan Cells

A

Principle antigen presenting cell for external eye

Rich in class II MHC molecules

Abundant at corner-scleral limbus
Less in peripheral cornea
Absent from central ⅓ of cornea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Conjunctiva

A

Only part of the eye with lymphatic drainage

Specialised endothelial venues for regulated migration of lymphoid cells

Diffuse lymphoid populations in all conjunctival zones
- CD4+ & CD 8+ T cells, IgA secreting plasma

Dendritic cells act as APCs

Mucosa associated lymphoid tissue (MALT)
- macrophages, langerhans and mast cells

Commensal bacteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Cornea and Sclera

A

‘Tough collagen coat’

Avascularity

No lymphatics or lymphoid tissue
Relative lack of APCs

langerhans cells only in peripheral cornea

Downregulated environment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Lacrimal Gland

A

More plasma cells (IgA) and CD8+ T cells compared to conjunctiva

T cells in small groups around interlobular ducts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Lacrimal Gland drainage system

A

Diffuse lymphoid tissue and follicles in mucosa (MALT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Vitreous, Choroid and Retina

A

Blood-ocular barrier

Relative lack of APCs

Downregulated immune environment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Immune privilege site

A

Able to tolerate introduction of antigens without exciting an inflammatory response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Sites of immune privilege in eye

A
Cornea
Anterior. chamber
Lens 
Vitreous Cavity
Sub-retinal space
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Ocular immune privilege mechanisms

A

Unique anatomical features of blood-tissue barrier and lack of direct lymphatic drainage

Ocular environment is rich in immunosuppressive molecules and inhibitory cell surface molecules that influence the reactivity of immune cells

Anterior chamber associated immune deviation
- ACAID

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Anterior chamber associated immune deviation

A

Placement of foreign antigen. into ocular microenvironment can induce a systemic form of tolerance to foreign antigen

‘Peripheral tolerance’ to ocular antigen

ACAID protects the eye and visual axis from collateral damage of an immune response to infection by suppressing a future potentially damaging response to infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Establishment of Ocular Immune Privilege

A

Separation
Inhibition
Regulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Establishment of Ocular Immune Privilege: Separation

A

Immunological Ignorance

Corneal cells have decreased expression of MHC class I and do not express MHC class II

Cornea lacks blood and lymphatic vessels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Establishment of Ocular Immune Privilege : Inhibition

A

Development of an intraocular immunosuppressive microenvironment

17
Q

Establishment of Ocular Immune Privilege : Regulation

A

Peripheral tolerance to ocular antigens

–> ACAID

18
Q

Sympathetic Ophthalmia

A

Rare, bilateral, granulomatous uveitis due to trauma or surgery to one eye

19
Q

Sympathetic Ophthalmia pathophysiology

A

Primary mediator: T cells

Initial wave of infiltrative cells composed of CD4+ helper T cells.
Later wave of infiltrative cells are CD8+ Cytotoxic T cells

20
Q

Sympathetic Ophthalmia Clinical

A

Injured eye: ‘exciting’ eye
Fellow eye: ‘sympathising’ eye

Clinically. both eyes will appear the same
History is required to determine exciting eye

21
Q

Ocular Autoimmune Diseases (5)

A

Autoimmune uveoretinities
- inflammation of urea and retina

Dalen-Fuchs Nodule
- Epithelial cells clusters in retinal layers

Jerato conjunctivitis Sicca
-dry eyes

lens-induced uveitis
- reaction due to release of lens products

Retina autoantibodies
- common in retinopathy associated with cancer/ infection/ degenerative disease

22
Q

Hypersensitivity Reactions

A

Type I: Immediate Hypersensitivity
Type 2: Direct cell killing
Type 3: Immune complex mediated
Type 4: Delayed type hypersensitivity

23
Q

Type 1 : Immediate hypersensitivity

A

Acute allergic conjunctivitis

- chemosis: oedema of conjunctivitis

24
Q

Type 2: Direct Cell Killing

A

(Antibody mediated cytotoxicity)

Ocular Cicatricial Pemphigoid

  • Type of autoimmune conjunctivitis
  • BListering and scarring of conjunctiva
25
Q

Type 3: Immune complex mediated

A

Outer layer of cornea melts and inner layer bulges forward: possible perforation

26
Q

Type 4: Delayed hypersensitivity

A

Corneal Graft rejection

- vascularisation of host cornea reaching the donor tissue = graft rejection

27
Q

Corneal Transplants and Immune Privilege

A

Factors that maintain immune privilege:

Reduced and impaired expression of MHC
Class I and Class II molecules in corneal cells
-reduced net antigenic load

Cornea lacks blood and lymph vessels

Central cornea is deficit in Langerhans Cells

Secretion of molecules with immunosuppressive properties

Expression of surface molecules that inhabit immune effectors

ACAID in recipients